维普期刊资源整合服务平台（V6.5）

56篇 您的检索式：作者名="Mandrekar S"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	PPARγ agonists as therapeutics for the treatment of Alzheimer's disease 显示文摘	Landreth G Jiang Q Mandrekar S	2008	Neurotherapeuties2008，5，3：	1
2	Existence of mild solutions for stochastic differential equations and semilinear equations with non-Gaussian Lrvy noise 显示文摘	ALBEVERIO S MANDREKAR V RUDIGER B	2009	Stochastic Processes and their Applications2009，119，3：	1
3	A phase Ⅱ NC-CTG/CALGB trial of imatinib (ST1571) in patients with c-kit-expressing relapsed small cell lung cancer (SCLC)显示文摘	Dy GK Miller AA Mandrekar S	2005	Proc Am Clin Soc Oncol2005，，：	1
4	The electricidal effect: reduction of Staphylococcus and Pseudomonas biofilms by prolonged exposure to low-intensity electrical current显示文摘	del POZO J L ROUSE M S MANDREKAR J N	2009	Antimicrobial Agents and Chemotherapy2009，53，1：	1
5	Combined basic research satellite symposium-session two:Toll-like receptors and organ damage显示文摘	Mandrekar P Pruett S Arteel G	2005	Alcohol Clin Exp Res2005，29，9：	1
6	Effect of ethanol on infiamma- toryresponses 显示文摘	Szabo G Mandrekar P Oak S	2007	Pancreatology2007，7，23：	1
7	A phase Ⅰ study of BAY43-9006 and gefitinib with refxactory or recurrent NSCLC 显示文摘	Adjei A Mandrekar S Marks RS et al	2005	J Clin Oncol2005，，：	1
8	Phase I trial of sorafenib in combination with gefitinib in patients with re- fractory or recurrent non -small cell lung cancer显示文摘	ADJEI A A MOLINA J R MANDREKAR S J	2007	Clin Cancer Res2007，13，9：	1
9	A randomized phase Ⅱ study of gemcitabine and carboplatin with or without cediranib as first-line therapy in advanced non-small-cell lung cancer: North Central Cancer Treatment Group Study N0528 显示文摘	Dy GK Mandrekar S J Nelson GD	2013	J Thorac Oncol2013，8，1：	1
10	Effect of electri- cal current on the activities of antimicrobial agents against Pseudomonas aeruginoso, Staphylococcus attreus, and Stapfiylococcus epidermidis biofilms显示文摘	DEL POZO J L ROUSE M S MANDREKAR J N	2009	Antimicrob Agents Ch2009，53，1：	1
11	Long - term safety and tolerability of sorafenib in patients with ad- vanced non - small - cell lung cancer: a case - based review 显示文摘	ADJEI A A BLUMENSCHEIN G R Jr MANDREKAR S	2011	Clin Lung Cancer2011，12，4：	1
12	The opposite effects of acute and chronic alcohol on lipopolysaccharide-induced inflammation are linked to IRAK-M in human monocytes显示文摘	Mandrekar P Bala S Catalano D		0，，2：	1
13	A review of phase II trial designs for initial marker validation显示文摘	Mandrekar S J An MW Sargent DJ	2013	Contemp Clin Trials2013，36，2：	1
14	PPAR-γ Agonists as Therapeutics for the Treatment of Alzheimer's Disease显示文摘	LANDRETH G JIANG Q MANDREKAR S	2008	Neurotherapeutics2008，5，3：	1
15	ApoE promotes the proteolytic degradation of Abeta 显示文摘	Jiang Q Lee CY Mandrekar S	2008	Neuron2008，58，5：	1
16	Thirty-and ninety-day outcomes after sublobar resection with and without brachytherapy for non-small cell lung cancer:results from a multicenter phaseⅢstudy显示文摘	Fernando H C Landreneau R J Mandrekar S J	2011	J Thorac Cardiovasc Surg2011，142，5：	1
17	Immunocy-tochemical localization of follicle-stimulating hormone in normalhuman stomach显示文摘	Mandrekar P S Sheth A R Doctor V M	1990	Anat Rec1990，227，3：	1
18	PPAR agonists as therapeutics for CNS trauma and neurological dis- eases显示文摘	Mandrekar Colucci S Sauerbeck A Popovich PG	2013	Asn Neuro2013，5，5：	1
19	Nuclear recep- tors as therapeutic targets for Alzheimer's disease显示文摘	Mandrekar Colucci S Landreth GE	2011	Expert Opin Ther Targets2011，15，9：	1
20	Pretreatment quality of life is an in- dependent prognostic factor for overall survival in patients with advanced stage non-small cell lung cancer显示文摘	Qi Y Schild SE Mandrekar S J	2009	J Thorac Oncol2009，4，9：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示